Oral Anticoagulation in Atrial Fibrillation

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 34-41

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Prestroke Oral Anticoagulation on Severity and Outcome of Ischemic and Hemorrhagic Stroke in Patients with Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 29, Iss. 5, 2010-03 ,pp. : 476-483

Karger

Access to resources Recommend Favorite

Do Population Studies Confirm the Benefit of Oral Anticoagulation in Atrial Fibrillation Demonstrated in Clinical Trials?: Current Topics in the Management of Atrial Fibrillation

By Willems Rik   Exner Derek V.  

Journal of Interventional Cardiac Electrophysiology, Vol. 10, Iss. 1, 2004-02 ,pp. : 9-16

Springer Publishing Company

Access to resources Recommend Favorite

Adherence and Quality of Oral Anticoagulation in Cerebrovascular Disease Patients with Atrial Fibrillation

By  

European Neurology, Vol. 60, Iss. 3, 2008-07 ,pp. : 142-148

Karger

Access to resources Recommend Favorite

Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF I) Registry

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 5, 2016-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite